Crossmark

Nanomedicine and macroscale materials in immuno-oncology

Crossref DOI link: https://doi.org/10.1039/C8CS00473K

Published Online: 2019

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Sun, Qingxue

Barz, Matthias https://orcid.org/0000-0002-1749-9034
De Geest, Bruno G. https://orcid.org/0000-0001-9826-6170
Diken, Mustafa

Hennink, Wim E. https://orcid.org/0000-0002-5750-714X
Kiessling, Fabian

Lammers, Twan https://orcid.org/0000-0002-1090-6805
Shi, Yang https://orcid.org/0000-0003-4530-2056
Funding

Funding for this research was provided by:

H2020 European Research Council (309495 (NeoNaNo), 680882 (CONQUEST), 813086 (PIcelles))

Fonds Wetenschappelijk Onderzoek

Universiteit Gent

Deutsche Forschungsgemeinschaft (RTG2375, SFB 1066-1/-2)

European Regional Development Fund (I3-STM 0800387)
License Information

Accepted Manuscript valid from 2019-11-22
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

IDENTIFIERS

: Matthias Barz (ORCID)

: Bruno G. De Geest (ORCID)

: Wim E. Hennink (ORCID)

: Twan Lammers (ORCID)

: Yang Shi (ORCID)

: Yang Shi (ResearcherID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 15 September 2018; Advance Article published 22 November 2018; Version of Record published 2 January 2019